Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing In AEterna Zentaris Inc. To Contact The Fir
July 06 2012 - 9:31AM
PR Newswire (Canada)
NEW YORK, July 6, 2012 /CNW/ - Faruqi & Faruqi, LLP, a leading
national securities law firm, has filed a class action lawsuit in
the United States District Court for the Southern District of New
York, Case # 12-Civ-4711, on behalf of all persons who purchased
AEterna Zentaris Inc. ("AEterna" or the "Company") securities
between February 3, 2010 and April 1, 2012 inclusive (the "Class
Period"). (Logo:
http://photos.prnewswire.com/prnh/20120119/MM38856LOGO ) AEterna,
AEterna's Chief Executive Officer Juergen Engel and AEterna's Chief
Financial Officer Dennis Turpin are charged with violations of
Section 10(b) and/or 20(a) of the Securities Exchange Act of 1934
and Rule 10b-5 promulgated thereunder. Specifically, Plaintiff's
complaint alleges that defendants misled investors about the timing
and success of AEterna's clinical trial that tested whether the
drug perifosine was effective in treating late stage colorectal
cancer. On April 2, 2012, AEterna shocked the market by disclosing
that perifosine was ineffective in treating colorectal cancer. This
news caused AEterna stock to drop approximately 66% by the close of
the business day. Request more information now by clicking here:
www.faruqilaw.com/AEZS. There is no cost or obligation to you. Take
Action Plaintiff now seeks to recover damages on behalf of himself
and all other individual and institutional investors who bought
AEterna securities between February 3, 2010 and April 1, 2012,
excluding defendants and their affiliates. Plaintiff is represented
by Faruqi & Faruqi, LLP, a law firm with extensive experience
in prosecuting class actions and actions involving corporate fraud.
If you purchased AEterna securities during the Class Period, and
would like to discuss your legal rights, visit
www.faruqilaw.com/AEZS. You can also contact us by calling Juan
Monteverde, Richard Gonnello or Francis McConville toll free at
877-247-4292 or at 212-983-9330 or by sending an e-mail to
jmonteverde@faruqilaw.com, rgonnello@faruqilaw.com or
fmcconville@faruqilaw.com. Faruqi & Faruqi, LLP also encourages
anyone with information regarding AEterna's conduct to contact the
firm, including whistleblowers, former employees, shareholders and
others. Attorney Advertising. The law firm responsible for this
advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com).
Prior results do not guarantee or predict a similar outcome with
respect to any future matter. We welcome the opportunity to discuss
your particular case. All communications will be treated in a
confidential matter. FARUQI & FARUQI, LLP369 Lexington Avenue,
10th FloorNew York, NY 10017Attn: Juan Monteverde, Esq.
jmonteverde@faruqilaw.com Richard Gonnello, Esq.
rgonnello@faruqilaw.com Francis McConville,
Esq.fmcconville@faruqilaw.com Telephone: (877) 247-4292 or (212)
983-9330 SOURCE Faruqi & Faruqi, LLP Faruqi & Faruqi, LLP
CONTACT:
http://www.faruqilaw.comhttp://photos.prnewswire.com/prnh/20120119/MM38856LOGOPRN
Photo Desk, photodesk@prnewswire.com
Copyright
Aeterna Zentaris (NASDAQ:AEZS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Aeterna Zentaris (NASDAQ:AEZS)
Historical Stock Chart
From Jul 2023 to Jul 2024